Home > Annual Financials > TRIDENT LIFELINE

TRIDENT LIFELINE Financial Statement Analysis
[BOM: 543616]

The Revenues of TRIDENT LIFELINE have increased by 40.82% YoY .
The Earnings Per Share (EPS) of TRIDENT LIFELINE has increased by 5.54 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TRIDENT LIFELINE Last 5 Annual Financial Results
[BOM: 543616]

ConsolidatedMar2024
Mar2023
Mar2022
Revenues ₹45 Cr₹32 Cr₹22 Cr
Expenses ₹36 Cr₹25 Cr₹19 Cr
Operating Profit (Excl OI) ₹8.23 Cr₹6.27 Cr₹2.71 Cr
Other Income ₹2.08 Cr₹1.16 Cr₹0.60 Cr
Interest ₹0.65 Cr₹0.48 Cr₹0.13 Cr
Depreciation ₹0.97 Cr₹0.37 Cr₹0.20 Cr
Profit Before Tax ₹8.70 Cr₹6.58 Cr₹2.98 Cr
Profit After Tax ₹5.94 Cr₹6.02 Cr₹3.95 Cr
Consolidated Net Profit ₹6.34 Cr₹6.02 Cr₹3.95 Cr
Earnings Per Share (Rs)₹5.52₹5.23₹4.93
PAT Margin (%)13.3118.9918.14
ROE(%)12.5224.2183.23
ROCE(%)15.3223.6043.21
Total Debt/Equity(x)0.370.170.52

Key Financials

Market Cap : ₹ 316.3 Cr
Revenue (TTM) : ₹ 41.9 Cr
Net Profit(TTM) : ₹ 6.4 Cr
EPS (TTM) : ₹ 5.6
P/E (TTM) : 49.2

Industry Peers & Returns1W1M1Y
TRIDENT LIFELINE -3.5% -11.5% 37.4%
SUN PHARMACEUTICAL INDUSTRIES -0.1% 1.7% 45.7%
CIPLA 1.7% 0.5% 23.7%
DR REDDYS LABORATORIES 5.7% 12.4% 18.5%
ZYDUS LIFESCIENCES -1.4% 3.1% 44.8%
DIVIS LABORATORIES -0.1% -2.2% 56.9%
MANKIND PHARMA 4.2% 9.8% 49.8%
TORRENT PHARMACEUTICALS 2.2% 10.6% 61.7%
LUPIN 4.1% 5.1% 71.7%


TRIDENT LIFELINE Revenues
[BOM: 543616]

Y-o-Y

40.82 %

5 Yr CAGR

43.19 %

Years Revenues % Change
Mar2024 ₹45 Cr
40.82
Mar2023 ₹32 Cr
45.59
Mar2022 ₹22 Cr -


TRIDENT LIFELINE Operating Profit
[BOM: 543616]

Y-o-Y

31.41 %

5 Yr CAGR

74.34 %

Years Operating Profit % Change
Mar2024 ₹8.23 Cr
31.41
Mar2023 ₹6.27 Cr
131.30
Mar2022 ₹2.71 Cr -

Operating Margins
Y-o-Y

-6.68 %

5 Yr CAGR

21.78 %

Years Operating Margin% % Change
Mar2024 18.45%
-6.68
Mar2023 19.77%
58.92
Mar2022 12.44% -

TRIDENT LIFELINE Profit After Tax
[BOM: 543616]

Y-o-Y

5.47 %

5 Yr CAGR

26.76 %

Years Profit After Tax % Change
Mar2024 ₹6.34 Cr
5.47
Mar2023 ₹6.02 Cr
52.36
Mar2022 ₹3.95 Cr -

PAT Margins
Y-o-Y

-29.91 %

5 Yr CAGR

-14.34 %

Years PAT Margin(%) % Change
Mar2024 13.31 %
-29.91
Mar2023 18.99 %
4.69
Mar2022 18.14 % -

TRIDENT LIFELINE Earnings Per Share (EPS)
[BOM: 543616]

Y-o-Y

5.54 %

5 Yr CAGR

5.81 %

Years EPS % Change
Mar2024 ₹5.52
5.54
Mar2023 ₹5.23
6.09
Mar2022 ₹4.93 -

TRIDENT LIFELINE Return on Capital Employed (ROCE)
[BOM: 543616]

Y-o-Y

-35.08 %

5 Yr CAGR

-40.46 %

Years ROCE % Change
Mar2024 15.32%
-35.08
Mar2023 23.6%
-45.38
Mar2022 43.21% -

TRIDENT LIFELINE Share Price vs Sensex

Current Share Price : ₹275.0
Current MarketCap: ₹ 316.3 Cr
Updated EOD on :Dec 19,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

-3.5%

-11.5%

37.4%

SENSEX

-5%

0.6%

9.2%

TRIDENT LIFELINE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about TRIDENT LIFELINE Financials


How the annual revenues of TRIDENT LIFELINE have changed ?

The Revenues of TRIDENT LIFELINE have increased by 40.82% YoY .

How the Earnings per Share (EPS) of TRIDENT LIFELINE have changed?

The Earnings Per Share (EPS) of TRIDENT LIFELINE has increased by 5.54 % YoY .